Search

Zai Lab Ltd ADR

Suletud

SektorTervishoid

19.46 0.67

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.81

Max

19.37

Põhinäitajad

By Trading Economics

Sissetulek

-607K

-51M

Müük

-28M

100M

Aktsiakasum

-0.46

Kasumimarginaal

-51.215

Töötajad

1,784

EBITDA

4.1M

-44M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+69.81% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-314M

2.1B

Eelmine avamishind

18.79

Eelmine sulgemishind

19.46

Zai Lab Ltd ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. juuli 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7. juuli 2026, 23:43 UTC

Social Media
News

Apple Inc. shares rose in after-hours trading, bolstered by a significant gain in a call option and an extended partnership with Broadcom through 2031.

7. juuli 2026, 23:41 UTC

News

Concerns over Middle East tensions and rising oil prices support gains in iShares 7-10 Year Treasury Bond ETF during after-hours trading.

7. juuli 2026, 23:41 UTC

Social Media
Correlated Moves
News

NVIDIA shares are lower in after-market trading as Michael Burry initiates short positions, citing concerns over reduced AI spending among businesses.

7. juuli 2026, 23:41 UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is higher in after-market trading, supported by gains from key holdings despite broader market pressures and geopolitical tensions.

7. juuli 2026, 23:41 UTC

ETF Constituents
Social Media
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in Invesco QQQ Trust during after-market hours, reflecting broader market concerns.

7. juuli 2026, 23:36 UTC

ETF Constituents
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in the Vanguard Growth ETF during after-market hours.

7. juuli 2026, 23:21 UTC

Social Media
News

Meta Platforms Inc. has gained after launching its Muse Image generator, enhancing user engagement despite facing $1.4 trillion in legal challenges.

7. juuli 2026, 23:06 UTC

News

Geopolitical tensions rise after U.S. strikes on Iran, while the Reserve Bank of New Zealand is set to announce a rate hike. The ETF traded roughly flat in after-market hours.

7. juuli 2026, 23:06 UTC

News

The United States Oil Fund LP is trading higher after military strikes against Iran escalated tensions, contributing to gains in WTI crude prices above $72.50.

7. juuli 2026, 23:06 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market trading amid broader market declines and concerns over chip stocks following Samsung's earnings report.

7. juuli 2026, 23:02 UTC

Correlated Moves
News

Silver is lower in after-market hours, reflecting declines since Tuesday's close amid rising tensions from U.S. military actions and expectations of a New Zealand rate hike.

7. juuli 2026, 23:01 UTC

ETF Constituents
Macro News
News

The Industrial Select Sector SPDR Fund declined in after-market hours amid geopolitical tensions and a hawkish Fed stance, impacting operating margins in the industrial sector.

7. juuli 2026, 23:01 UTC

Social Media
News

T-Mobile US Inc. appointed Chris Sambar as Chief Enterprise Officer, effective by October 14, 2026, and shares traded higher in after-market hours.

7. juuli 2026, 22:51 UTC

News

PayPal shares are lower in after-market hours following Barclays' Underweight rating and price target of $42.00, amid broader market weakness and geopolitical tensions.

7. juuli 2026, 20:07 UTC

News
Correlated Moves

Bitcoin declines amid geopolitical tensions following missile attacks in the Strait of Hormuz. Regulatory approval for Bitcoin Suisse in the UAE adds complexity to investor sentiment.

7. juuli 2026, 20:07 UTC

Correlated Moves
News

Bitcoin is lower today amid rising geopolitical tensions and concerns over oil supply disruptions. Ethereum's decline may also influence Bitcoin's price movement.

7. juuli 2026, 20:06 UTC

Social Media
News
Correlated Moves

Synopsys Inc. is discontinuing its manufacturing process control software for semiconductor makers, shifting focus to AI design offerings. Shares are trading lower today.

7. juuli 2026, 20:06 UTC

Social Media
News

Amazon.com Inc shares are higher following a $25 billion bond sale to fund AI infrastructure, attracting $62 billion in demand and receiving an 'AA-' rating from Fitch.

7. juuli 2026, 20:06 UTC

News
Social Media
Correlated Moves

Broadcom Inc shares are lower today following a downgrade to Hold by Erste Group, amid broader declines in the semiconductor sector.

7. juuli 2026, 20:06 UTC

News
Correlated Moves

Ethereum is trading lower following a suspicious transaction linked to an exploiter, resulting in estimated losses of around $6 million.

7. juuli 2026, 20:04 UTC

News
Social Media

Tesla Inc. shares are lower today amid criticism of CEO Elon Musk's governance linked to negative brand perception, despite RBC raising its price target to $500.

7. juuli 2026, 20:03 UTC

Social Media
News

Fiserv is in talks to sell its debit card network for about $15 billion. Shares are trading lower amid market volatility despite earlier gains.

7. juuli 2026, 20:03 UTC

News
Correlated Moves

Analog Devices has completed its acquisition of Empower Semiconductor to enhance AI capabilities. Shares are declining amid broader market pressures affecting the semiconductor sector.

7. juuli 2026, 20:02 UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

7. juuli 2026, 19:52 UTC

Social Media
News
Correlated Moves

Alphabet Inc. is under investigation in Nigeria for alleged anti-competitive practices, contributing to a decline in shares during Tuesday's session.

7. juuli 2026, 19:46 UTC

News
Social Media
Correlated Moves

Costco faces scrutiny from a class-action lawsuit alleging toxic heavy metals in its protein products, contributing to shares trading lower since Monday's close.

7. juuli 2026, 19:44 UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

7. juuli 2026, 19:36 UTC

News
Correlated Moves

Ethereum is trading lower amid a suspicious transaction linked to an exploiter, resulting in estimated losses of $6 million and concerns over price manipulation.

7. juuli 2026, 19:36 UTC

News
Social Media

Vertex Pharmaceuticals shares are lower today following its $10 billion acquisition of Crinetics Pharmaceuticals, despite analyst support and price target increases.

Võrdlus sarnastega

Hinnamuutus

Zai Lab Ltd ADR Prognoos

Hinnasiht

By TipRanks

69.81% tõus

12 kuu keskmine prognoos

Keskmine 32.4 USD  69.81%

Kõrge 44 USD

Madal 21.6 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Zai Lab Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

3

Osta

1

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat